TEANECK, N.J., March 30, 2016 -- Phibro Animal Health Corporation (NASDAQ:PAHC) will host a webcast and conference call to review third quarter financial results. A news release containing quarterly results is expected to be issued after the market closes on Monday, May 9, 2016.
Details for the webcast and conference call:
| Date: | Tuesday, May 10, 2016 | |||
| Time: | 9:00 AM Eastern Time | |||
| Location: | http://investors.pahc.com | |||
| U.S. Toll-Free: | +1 (877) 853-5634 | |||
| International Toll: | +1 (315) 625-6893 | |||
| Conference ID: | 52883099 | |||
NOTE: In order to join this conference call, all participants will be required to provide the Conference ID number.
Archive: A replay of the webcast and conference call will be available on Phibro’s website.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. The company reported net sales of $749 million for the fiscal year ended June 30, 2015. For further information, please visit www.pahc.com.
Our filings with the Securities and Exchange Commission are available online at www.sec.gov, www.pahc.com or on request from the company.
Contact: Richard Johnson Phibro Animal Health Corporation Chief Financial Officer +1-201-329-7300 [email protected]


ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 



